Discussion  by unknown
8. Takeuchi K, McGowan FX Jr, Bacha EA, Mayer JE Jr, Zurakowski D, Otaki M,
et al. Analysis of surgical outcome in complex double-outlet right ventricle with
heterotaxy syndrome or complete atrioventricular canal defect. Ann Thorac Surg.
2006;82:146-52.
9. Kim SJ, Kim WH, Lim HG, Lee CH, Lee JY. Improving results of the Fontan
procedure in patients with heterotaxy syndrome. Ann Thorac Surg. 2006;82:
1245-51.
10. Dickinson DF, Wilkinson JL, Anderson KR, Smith A, Ho SY, Anderson RH.
The cardiac conduction system in situs ambiguus. Circulation. 1979;59:
879-85.
11. Ho SY, Fagg N, Anderson RH, Cook A, Allan LD. Disposition of the atrioventric-
ular conduction tissues in the heart with isomerism of the atrial appendages: its
relation to congenital heart block. J Am Coll Cardiol. 1992;20:904-10.
12. Hancock Freisen CL, Sherwood MC, Gauvreau K, Frank DF, del Nido PJ,
Jonas RA, et al. Intermediate outcomes of atrioventricular valvuloplasty in lateral
tunnel Fontan patients. J Heart Valve Dis. 2004;13:962-71.
13. Van Praagh R, Van Praagh S. Atrial isomerism in the heterotaxy syndromes with
asplenia, or polysplenia, or normally formed spleen: an erroneous concept. Am J
Cardiol. 1990;66:1504-6.
14. Sinzobahamvya N, Arenz C, Brecher AM, Urban AE. Atrial isomerism: a surgical
experience. Cardiovasc Surg. 1999;7:436-42.
15. van Son JA, Black MD, Haas GS, Falk V, Hambsch J, Onnasch JF, et al. Extrac-
ardiac repair versus intracardiac baffle repair of complex unroofed coronary sinus.
Thorac Cardiovasc Surg. 1998;46:371-4.
16. Sapire DW, Ho SY, Anderson RH, RigbyML. Diagnosis and significance of atrial
isomerism. Am J Cardiol. 1986;58:342-6.
17. Marcelletti C, Di Donato R, Nijveld A, Squitieri C, Bulterijs AH, Naeff M, et al.
Right and left isomerism: the cardiac surgeon’s view. Ann Thorac Surg. 1983;35:
400-5.
18. Freedom RM, Van Arsdell GS. Biventricular hearts not amenable to biventricular
repair. Ann Thorac Surg. 1998;66:641-3.
19. Yun TJ, Al-Radi OO, Adatia I, Caldarone CA, Coles JG, Williams WG, et al.
Contemporary management of right atrial isomerism: effect of evolving therapeu-
tic strategies. J Thorac Cardiovasc Surg. 2006;131:1108-13.
Discussion
Dr Marshall L. Jacobs (Philadelphia, Pa). Thank you, Dr
Pigula, for sharing this wealth of information with us. To you
and your associates, congratulations on the very fine results with
these difficult patients.
In 2002 I had the privilege of discussing a paper from the same
institution titled ‘‘Improving Results of the Modified Fontan Opera-
tion in Patients with Heterotaxy Syndrome’’ (Ann Thorac Surg.
2002;74:1967-78). Dr Christof Stamm at that time reported the re-
sults of 135 Fontan procedures. Nearly three fourths of them were
in the decade between 1990 and 2000. Right isomerism predomi-
nated over left, which was the opposite of your pattern of predomi-
nance in the current series. For patients after 1991, in the Fontan
series, the early mortality was just 3%, which is very similar to yours,
and the Kaplan–Meier 10-year survival was 93%, which is identical
to what you have shown. The risk factors for mortality were anom-
alous pulmonary venous connection and increased pulmonary vascu-
lar resistance. Not surprisingly, in the Fontan group, the previous
bidirectional Glenn anastomosis had a positive impact on survival.
Today you have shown us the other side of the coin—91 hetero-
taxy patients who underwent two-ventricle repair during a time in-
terval when, according to your manuscript, an additional 280
heterotaxy patients underwent Fontan operations. The only risk fac-
tor in your series for mortality was unbalanced AV canal defect.
The survivors tended to be younger patients. Freedom from
arrhythmia was 60% at 5 years and 55% at 10 years. Freedom
from reoperation and reintervention were actually considerably
less for the biventricular repair group than for the Fontan cohort
if one excludes device closure of fenestrations.
At follow-up in your series, the vast majority of patients under-
going biventricular repair were in NYHA functional class I, despite
the relatively high incidence of reinterventions and arrhythmias.
This was considerably higher than the fraction of the Fontan
patients in NYHA class I.
My first question is as follows:
Your manuscript includes the statement: ‘‘Patients with unbal-
anced complete atrioventricular canal are a high-risk group for
which selection criteria are particularly important.’’ You point
out that the patients in that diagnostic group were believed by the
cardiologists to have mildly unbalanced CAVC, and only 1 patient
had undergone a bidirectional Glenn before biventricular repair.
Another patient underwent a bidirectional Glenn as part of a subse-
quent re-repair or bailout. What criteria would you now apply to
determine the best pathway for patients with mild ventricular
imbalance? If those criteria are still illusive, might there be a greater
role for staging with a bidirectional Glenn that could culminate in
a biventricular repair or even a one-and-a-half ventricle repair?
Dr Pigula. Thank you for your comments. You are absolutely
right. The unbalanced ventricle has been the problematic patient
group, and it is not problematic just in this situation, of course.
When we evaluate these patients, we look at the typical anatomy,
or the typical components of the anatomy. For biventricular repair
we should require that the ventricle be of adequate size, possess
adequate function, have adequate dedicated AV valve tissue, and
adequate outflow tracts.
Now, quantifying those points is where it becomes difficult. That
is where an overall evaluation of the composite anatomy, rather
than the component anatomy, gets to be difficult. It is a matter of
judgment in most cases. The fundamental issue with this kind of
study, as well as the previous Fontan study out of our institution
with heterotaxy, is patient selection. That is something that this
paper did not address. It is a very difficult topic to try to quantify
and report on, and that is why we have not been able to do that.
However, I think the fundamental issue is which patients are
directed toward which treatment strategy. I think that that is really
exposed with the unbalanced canal defect because that is where the
patients are at risk. Thus I do not have a discrete or a definite answer
for you in terms of using criteria A, B, and C, but rather a judgment
about the aggregate anatomy.
Dr Jacobs. I have just one other question. In your arrhythmia
follow-up data in the paper, youmentioned that there were a number
of patients who had either ventricular tachycardia or ventricular
fibrillation and required radiofrequency ablation or AICD. Were
those late postoperative events? Is that an ongoing risk factor for
these patients? Is there any evidence that it is related to septal resec-
tion or any other aspect of septation for biventricular repair?
Dr Pigula. I do not know the answer to that, but my instinct/
intuition about it is that it is related to the amount of intracardiac
work. If you compare the two series, the Fontan series and this
series, certainly our freedom from arrhythmia is less than we see
in the Fontan group. I think that is probably related to the amount
of intracardiac work, in some cases VSD enlargement or incisions
in the ventricle, and I think all of those add to it. I do think that they
are going to have a greater degree of electrical instability over the
long term and that will continue.
Dr Hiromi Kurosawa (Tokyo, Japan). Dr Pigula, right isomer-
ism heart, so-called asplenia, usually has a dominant right ventricle
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with common AV valve. According to your abstract, 9 patients had
right isomerism. Did you do the biventricular repair for those pa-
tients who had asplenia with common AV valve?
Dr Pigula. Most of those patients had a common AV valve. I
think it was 6 patients who had a common AV valve. Also, several
of those patients had L-transposition of the great vessels as well.
Dr Kurosawa. Usually the asplenia heart has a very small left
ventricle and a large right ventricle, so that it is sometimes difficult
to divide the right ventricle into 2 ventricles.
Dr Pigula. I think your question is septating the AV valve in this
setting?
Dr Kurosawa. Yes, and also the ventricle.
Dr Pigula. Well, of course, it gets back, again, to the issue of
patient selection. These patients were only accepted for biventricu-
lar repair if we thought they had septatable ventricles that we could
connect to their appropriate outflow tract and a septatable valve.
I think an important point is that you can have components, those
components, the AV valve, the ventricular mass and size, and the
outflow tracts, that are all adequate in isolation, but when you put
together a composite anatomy, they still may not add up to a biven-
tricular repair. You may still have cases in which you have func-
tional components, but in aggregate they are not amenable to
biventricular repair. These were carefully selected patients in
whom we thought we could achieve a biventricular repair.
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